Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
The FDA document was updated May 14, 2026 to reflect the reversal and to flag that the agency will consult the Pharmacy Compounding Advisory Committee, or PCAC, before the end of February 2027 about whether GHK-Cu should be added to the permanent 503A bulks list
Some previous studies supported our results
2nd ed., Wiley-Blackwell, 2009
Product Specifications Product Name: GHK-Cu (Copper Tripeptide-1) Chemical Name: Gly-His-LysCu Molecular Formula: CHCuNO Molecular Weight: Approximately 403.92 g/mol Peptide Length: 3 Amino Acids Purity: 95% (HPLC Verified) Form: Lyophilized Powder Recommended Storage: Store at 20C in a dry environment, protected from light
Abstract Dilated cardiomyopathy is a myocardial condition marked by the enlargement of the heart's ventricular chambers and the gradual decline in systolic function, frequently resulting in congestive heart failure
